Migpex Tablet SR is a once-daily, controlled-release formulation containing a fixed dose combination of 10mg propranolol and 40mg flunarizine. This proprietary blend is designed to provide comprehensive management of migraine and tension-type headaches, as well as prevention of cluster headaches. Propranolol, a beta-blocker, contributes to the medication's analgesic and anti-inflammatory effects, while flunarizine, a calcium channel blocker, inhibits the entry of calcium ions into the neurons, thereby reducing the transmission of pain signals. The sustained-release technology ensures a steady and predictable release of the active ingredients over a 24-hour period, providing a consistent therapeutic effect. Migpex Tablet SR is indicated for the prophylactic treatment of frequent or severe migraines, tension-type headaches, and cluster headaches, as well as the treatment of acute migraine attacks. Its unique combination and controlled-release profile make it an attractive option for patients seeking effective and convenient relief from headache-related symptoms.